CARDIOFLOW-B (02160) has issued approximately 3.954 billion shares of bonus shares.
Heart Communication Medical -B (02160) announced that it will complete the issuance of approximately 3.954 billion shares of consideration shares on December 19, 2025, with an issuance price of HK$1.35 per share.
CARDIOFLOW-B (02160) announced that it completed the issuance of approximately 3.954 billion shares of cost shares on December 19, 2025, with an issuance price of HK$1.35 per share.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
